Explore relationships stated by the original sources. Each number opens its exact collection—not a count of extra papers or proven treatments.
Research ↔ organizationOctober 15, 2025
Development of Age‐ and Sex‐Specific Metabolomics‐Based Biological Ageing Clocks for 10‐Year Mortality Prediction
Organization linked by OpenAIRE · German Cancer Research Center
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →FDA application actionOctober 15, 2025
liraglutide
Approved submission · SUPPL 3
A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.
Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
Chemotherapy accelerated bone ageing is reversed by NMN
Organization linked by OpenAIRE · Harvard University
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
Chemotherapy accelerated bone ageing is reversed by NMN
Organization linked by OpenAIRE · University of Queensland
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
Chemotherapy accelerated bone ageing is reversed by NMN
Organization linked by OpenAIRE · Royal Women's Hospital
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
Chemotherapy accelerated bone ageing is reversed by NMN
Organization linked by OpenAIRE · UNSW Sydney
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
Cellular senescence in cancer: Unveiling dual roles, tumor microenvironment dynamics and therapeutic innovations (Review)
Organization linked by OpenAIRE · Shanghai University of Traditional Chinese Medicine
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
Cellular senescence in cancer: Unveiling dual roles, tumor microenvironment dynamics and therapeutic innovations (Review)
Organization linked by OpenAIRE · Tongji University
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
Cellular senescence in cancer: Unveiling dual roles, tumor microenvironment dynamics and therapeutic innovations (Review)
Organization linked by OpenAIRE · Central Hospital of Putuo District
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
From Lifespan Inequality to Lifespan Inequity
Organization linked by OpenAIRE · National Institute of Health
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
From Lifespan Inequality to Lifespan Inequity
Organization linked by OpenAIRE · National Institutes of Health
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
From Lifespan Inequality to Lifespan Inequity
Organization linked by OpenAIRE · Max Planck Society
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
From Lifespan Inequality to Lifespan Inequity
Organization linked by OpenAIRE · Max Planck Institute for Demographic Research
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
From Lifespan Inequality to Lifespan Inequity
Organization linked by OpenAIRE · Austrian Academy of Sciences
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
From Lifespan Inequality to Lifespan Inequity
Organization linked by OpenAIRE · Tel Aviv University
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
From Lifespan Inequality to Lifespan Inequity
Organization linked by OpenAIRE · Vienna Institute of Demography
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
From Lifespan Inequality to Lifespan Inequity
Organization linked by OpenAIRE · Johannes Kepler University of Linz
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →Research ↔ organizationOctober 14, 2025
From Lifespan Inequality to Lifespan Inequity
Organization linked by OpenAIRE · MEDIZINISCHE UNIVERSITAT GRAZ
An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.
Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence
Inspect the source record →FDA application actionOctober 14, 2025
liraglutide
Approved submission · SUPPL 26
A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.
Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence
Inspect the source record →FDA application actionOctober 14, 2025
liraglutide
Approved submission · SUPPL 46
A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.
Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence
Inspect the source record →FDA application actionOctober 14, 2025
liraglutide
Approved submission · SUPPL 22
A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.
Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence
Inspect the source record →FDA application actionOctober 14, 2025
semaglutide
Approved submission · SUPPL 35
A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.
Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence
Inspect the source record →FDA application actionOctober 14, 2025
semaglutide
Approved submission · SUPPL 37
A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.
Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence
Inspect the source record →FDA application actionOctober 14, 2025
semaglutide
Approved submission · SUPPL 26
A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.
Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence
Inspect the source record →